{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:39:35Z","timestamp":1790746775371,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":547,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.exphem.2022.09.004","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T23:38:40Z","timestamp":1664581120000},"page":"43-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Preclinical studies on the use of a P-selectin-blocking monoclonal antibody to halt progression of myelofibrosis in the Gata1 mouse model"],"prefix":"10.1016","volume":"117","author":[{"given":"Paola","family":"Verachi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4082-4675","authenticated-orcid":false,"given":"Francesca","family":"Gobbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Falchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"di Virgilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6405-3484","authenticated-orcid":false,"given":"Giuseppe","family":"Sarli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Wilke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bruederle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirudh","family":"Prahallad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Arciprete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Zingariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1800-271X","authenticated-orcid":false,"given":"Anna Rita","family":"Migliaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2022.09.004_bib0001","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3324\/haematol.2015.141283","article-title":"Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies","volume":"101","author":"Zahr","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2022.09.004_bib0002","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/s41375-018-0077-1","article-title":"Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet","volume":"32","author":"Barbui","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2022.09.004_bib0003","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.clml.2020.01.008","article-title":"The myelodepletive phenotype in myelofibrosis: clinical relevance and therapeutic implication","volume":"20","author":"Marcellino","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.exphem.2022.09.004_bib0004","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1182\/blood.2019000943","article-title":"Leukemia secondary to myeloproliferative neoplasms","volume":"136","author":"Dunbar","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.004_bib0005","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/onc.2012.347","article-title":"JAK\/STAT signaling in hematological malignancies","volume":"32","author":"Vainchenker","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2022.09.004_bib0006","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2018.068","article-title":"Megakaryocyte contribution to bone marrow fibrosis: many arrows in the quiver","volume":"10","author":"Malara","year":"2018","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.exphem.2022.09.004_bib0007","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1182\/blood.V96.4.1342","article-title":"Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis","volume":"96","author":"Schmitt","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.004_bib0008","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1182\/blood-2004-01-0193","article-title":"Increased and pathologic emperipolesis of neutrophils within megakaryocytes associated with marrow fibrosis in GATA-1low mice","volume":"104","author":"Centurione","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.004_bib0009","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0002-9440(10)62056-1","article-title":"Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis","volume":"167","author":"Vannucchi","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.exphem.2022.09.004_bib0010","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI82905","article-title":"Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis","volume":"127","author":"Gilles","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2022.09.004_bib0011","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood-2014-01-453167","article-title":"Erythro-megakaryocytic transcription factors associated with hereditary anemia","volume":"123","author":"Crispino","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.004_bib0012","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2002-06-1913","article-title":"Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice)","volume":"100","author":"Vannucchi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.004_bib0013","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1158\/1078-0432.CCR-18-4089","article-title":"Activation of JAK\/STAT signaling in megakaryocytes sustains myeloproliferation in vivo","volume":"25","author":"Woods","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2022.09.004_bib0014","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/stem.2888","article-title":"JAK2V617F megakaryocytes promote hematopoietic stem\/progenitor cell expansion in mice through thrombopoietin\/MPL signaling","volume":"36","author":"Zhang","year":"2018","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2022.09.004_bib0015","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1182\/blood-2006-12-064626","article-title":"Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis","volume":"110","author":"Ciurea","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.004_bib0016","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cyto.2010.07.427","article-title":"Evaluation of the bioactive and total transforming growth factor \u03b21 levels in primary myelofibrosis","volume":"53","author":"Campanelli","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.exphem.2022.09.004_bib0017","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood-2002-04-1133","article-title":"Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice","volume":"100","author":"Chagraoui","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.004_bib0018","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.exphem.2006.08.016","article-title":"Adenoviral-mediated TGF-beta1 inhibition in a mouse model of myelofibrosis inhibit bone marrow fibrosis development","volume":"35","author":"Gastinne","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2022.09.004_bib0019","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1182\/blood-2012-06-439661","article-title":"Characterization of the TGF-beta1 signaling abnormalities in the Gata1low mouse model of myelofibrosis","volume":"121","author":"Zingariello","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.004_bib0020","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145651","article-title":"TGF-\u03b21 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis","volume":"6","author":"Varricchio","year":"2021","journal-title":"JCI Insight"},{"issue":"Suppl 1","key":"10.1016\/j.exphem.2022.09.004_bib0021","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1182\/blood-2020-137265","article-title":"Duration of response to luspatercept in patients (Pts) requiring red blood cell (RBC) transfusions with myelofibrosis (MF) \u2013 updated data from the Phase 2 ACE-536-MF-001 Study","volume":"136","author":"Gerds","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.004_bib0022","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/09537104.2013.840720","article-title":"Abnormal P-selectin localization during megakaryocyte development determines thrombosis in the gata1low model of myelofibrosis","volume":"25","author":"Zetterberg","year":"2014","journal-title":"Platelets"},{"key":"10.1016\/j.exphem.2022.09.004_bib0023","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1083\/jcb.118.2.445","article-title":"Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells","volume":"118","author":"Moore","year":"1992","journal-title":"J Cell Biol"},{"key":"10.1016\/j.exphem.2022.09.004_bib0024","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1182\/blood.V93.3.876","article-title":"Platelet\/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b\/CD18 adhesion: role of PSGL-1 as a signaling molecule","volume":"93","author":"Evangelista","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.004_bib0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000203671","article-title":"Apoptosis (programmed cell death) in idiopathic (primary) osteo-\/myelofibrosis: naked nuclei in megakaryopoiesis reveal features of para-apoptosis","volume":"97","author":"Thiele","year":"1997","journal-title":"Acta Haematol"},{"key":"10.1016\/j.exphem.2022.09.004_bib0026","first-page":"34","article-title":"A novel interaction between megakaryocytes and activated fibrocytes increases TGF-\u03b2 bioavailability in the Gata1low mouse model of myelofibrosis","volume":"5","author":"Zingariello","year":"2015","journal-title":"Am J Blood Res"},{"key":"10.1016\/j.exphem.2022.09.004_bib0027","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/stem.2229","article-title":"P-Selectin sustains extramedullary hematopoiesis in the Gata1low model of myelofibrosis","volume":"34","author":"Spangrude","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2022.09.004_bib0028","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.exphem.2016.08.007","article-title":"Preclinical rationale for TGF-\u03b2 inhibition as a therapeutic target for the treatment of myelofibrosis","volume":"44","author":"Ceglia","year":"2016","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2022.09.004_bib0029","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2022.09.004_bib0030","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/blood-2004-02-0713","article-title":"The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo","volume":"104","author":"Embury","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.004_bib0031","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1182\/blood-2005-03-1060","article-title":"Variegation of the phenotype induced by the Gata1low mutation in mice of different genetic backgrounds","volume":"106","author":"Martelli","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.004_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bcj.2017.51","article-title":"The thrombopoietin\/MPL axis is activated in the Gata1low mouse model of myelofibrosis and is associated with a defective RPS14 signature","volume":"7","author":"Zingariello","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.exphem.2022.09.004_bib0033","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.stem.2013.05.014","article-title":"SLAM family markers resolve functionally distinct subpopulations of hematopoietic stem cells and multipotent progenitors","volume":"13","author":"Oguro","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2022.09.004_bib0034","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.exphem.2022.09.004_bib0035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/biom12020234","article-title":"Resident self-tissue of proinflammatory cytokines rather than their systemic levels correlates with development of myelofibrosis in Gata1low mice","volume":"12","author":"Zingariello","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.exphem.2022.09.004_bib0036","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1182\/blood.V93.9.2867.409k24_2867_2875","article-title":"Consequences of GATA-1 deficiency in megakaryocytes and platelets","volume":"93","author":"Vyas","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.004_bib0037","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/188585a0","article-title":"Biotin in the synthesis of fatty acid and cholesterol by mammalian liver","volume":"188","author":"Fletcher","year":"1960","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2022.09.004_bib0038","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)00121-5","article-title":"TGFbeta signaling in growth control, cancer, and heritable disorders","volume":"103","author":"Massagu\u00e9","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2022.09.004_bib0039","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1182\/blood-2009-03-211680","article-title":"Gata1 expression driven by the alternative HS2 enhancer in the spleen rescues the hematopoietic failure induced by the hypomorphic Gata1low mutation","volume":"114","author":"Migliaccio","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.004_bib0040","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1182\/blood.2021013925","article-title":"HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression","volume":"139","author":"Li","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.004_bib0041","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1369\/jhc.6A7164.2007","article-title":"Expression of bone morphogenetic proteins and their receptors in the bone marrow megakaryocytes of GATA-1(low) mice: a possible role in osteosclerosis","volume":"55","author":"Garimella","year":"2007","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.exphem.2022.09.004_bib0042","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1359\/JBMR.0301254","article-title":"Megakaryocyte\u2013osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2","volume":"19","author":"Kacena","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.exphem.2022.09.004_bib0043","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1182\/blood.2021011480","article-title":"Myeloproliferative disorders and its effect on bone homeostasis: the role of megakaryocytes","volume":"139","author":"Karagianni","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.004_bib0044","doi-asserted-by":"crossref","first-page":"C177","DOI":"10.1152\/ajpcell.00328.2021","article-title":"Megakaryocyte-bone cell interactions: lessons from mouse models of experimental myelofibrosis and related disorders","volume":"322","author":"Stavnichuk","year":"2022","journal-title":"Am J Cell Physiol"},{"key":"10.1016\/j.exphem.2022.09.004_bib0045","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3390\/cells8080854","article-title":"Roles of JAK2 in aging, inflammation, hematopoiesis and malignant transformation","volume":"8","author":"Perner","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.exphem.2022.09.004_bib0046","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/imm.12469","article-title":"Human spleen microanatomy: why mice do not suffice","volume":"145","author":"Steiniger","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.exphem.2022.09.004_bib0047","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood.2021010697","article-title":"Single-cell analysis of ploidy and the transcriptome reveals functional and spatial divergency in murine megakaryopoiesis","volume":"138","author":"Sun","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.004_bib0048","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2006-07-030726","article-title":"The hypomorphic Gata1low mutation alters the proliferation\/differentiation potential of the common megakaryocytic-erythroid progenitor","volume":"109","author":"Ghinassi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.004_bib0049","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI117430","article-title":"C5a-induced expression of P-selectin in endothelial cells","volume":"94","author":"Foreman","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2022.09.004_bib0050","doi-asserted-by":"crossref","first-page":"853484","DOI":"10.3389\/fonc.2022.853484","article-title":"The CXCR1\/CXCR2 inhibitor reparixin alters the development of myelofibrosis in the Gata1low mice","volume":"12","author":"Verachi","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.exphem.2022.09.004_bib0051","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1182\/blood-2003-12-4415","article-title":"IL-8 and its CXCR1 and CXCR2 receptors participate in the control of megakaryocytic proliferation, differentiation, and ploidy in myeloid metaplasia with myelofibrosis","volume":"105","author":"Emadi","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.004_bib0052","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1073\/pnas.94.15.7976","article-title":"An upstream, DNase I hypersensitive region of the hematopoietic-expressed transcription factor GATA-1 gene confers developmental specificity in transgenic mice","volume":"94","author":"McDevitt","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2022.09.004_bib0053","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/nm.3995","article-title":"Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition","volume":"21","author":"Wen","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2022.09.004_bib0054","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3324\/haematol.2019.226332","article-title":"Platelet-derived growth factor receptor \u03b2 activation and regulation in murine myelofibrosis","volume":"105","author":"Kramer","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2022.09.004_bib0055","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1111\/jcmm.13710","article-title":"Captopril mitigates splenomegaly and myelofibrosis in the Gata1low murine model of myelofibrosis","volume":"22","author":"Corey","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.exphem.2022.09.004_bib0056","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s12185-019-02751-6","article-title":"Novel lysyl oxidase inhibitors attenuate hallmarks of primary myelofibrosis in mice","volume":"110","author":"Leiva","year":"2019","journal-title":"Int J Hematol"},{"key":"10.1016\/j.exphem.2022.09.004_bib0057","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000445247","article-title":"The degree of anisocytosis predicts survival in patients with primary myelofibrosis","volume":"136","author":"Lucijanic","year":"2016","journal-title":"Acta Haematol"},{"key":"10.1016\/j.exphem.2022.09.004_bib0058","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.4049\/jimmunol.170.9.4612","article-title":"TGF-\u03b21 regulates lymphocyte homeostasis by preventing activation and subsequent apoptosis of peripheral lymphocytes","volume":"170","author":"Bommireddy","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2022.09.004_bib0059","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-\u03b2 signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.exphem.2022.09.004_bib0060","first-page":"391","article-title":"Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation","volume":"72","author":"Mukaida","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1016\/j.exphem.2022.09.004_bib0061","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1590\/S1679-45082015RB3438","article-title":"Chemokines and immunity","volume":"13","author":"Palomino","year":"2015","journal-title":"Einstein (S\u00e3o Paulo)"},{"key":"10.1016\/j.exphem.2022.09.004_bib0062","doi-asserted-by":"crossref","DOI":"10.1172\/JCI137377","article-title":"Lung megakaryocytes are immune modulatory cells","volume":"131","author":"Pariser","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2022.09.004_bib0063","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.stem.2020.11.006","article-title":"Decoding human megakaryocyte development","volume":"28","author":"Wang","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2022.09.004_bib0064","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.1182\/bloodadvances.2020002843","article-title":"Lung megakaryocytes display distinct transcriptional and phenotypic properties","volume":"4","author":"Yeung","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2022.09.004_bib0065","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/stem.2285","article-title":"Thrombopoietin\/TGF-\u03b21 loop regulates megakaryocyte extracellular matrix component synthesis","volume":"34","author":"Abbonante","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2022.09.004_bib0066","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/stem.1626","article-title":"Megakaryocytes contribute to the bone marrow-matrix environment by expressing fibronectin, type IV collagen, and laminin","volume":"32","author":"Malara","year":"2014","journal-title":"Stem Cells"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X22006981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X22006981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:38:00Z","timestamp":1759567080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X22006981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":66,"alternative-id":["S0301472X22006981"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2022.09.004","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical studies on the use of a P-selectin-blocking monoclonal antibody to halt progression of myelofibrosis in the Gata1low mouse model","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2022.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 ISEH \u2013 Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}